Cinnarizine-induced parkinsonism: Ten years later

Movement Disorders

Volumn 13, Issue 3, 1998, Pages 453-456

  Martí Massó, José F ^a,b   Poza, Juan J ^a  

^a Hospital Nuestra Senora de Aranzazu   (Spain)

^b Travesía del Helecho 3o Izda   (Spain)

Author keywords

Cinnarizine; Clinical characteristics; Drug induced parkinsonism; Evolution

Indexed keywords

AMIODARONE; CINNARIZINE; CLEBOPRIDE; CLOTIAPINE; DILTIAZEM; FLUNARIZINE; FLUOXETINE; FLUPENTIXOL; HALOPERIDOL; LEVOMEPROMAZINE; METHYLDOPA; METOCLOPRAMIDE; PERPHENAZINE; PIPERAZINE; RESERPINE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; VERALIPRIDE; VERAPAMIL;

ADULT; AGED; ARTICLE; DRUG INDUCED DISEASE; FEMALE; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYMPTOM; TARDIVE DYSKINESIA; TIME; VERTIGO;

AGED; CINNARIZINE; DIZZINESS; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE, SECONDARY; RETROSPECTIVE STUDIES; SPAIN; SUBSTANCE WITHDRAWAL SYNDROME; VERTEBROBASILAR INSUFFICIENCY;

EID: 2642699936     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130313     Document Type: Article

References (18)

1. Micheli FE, Pardal MM, Giannaula R, et al. Movement disorders and depression due to flunarizine and cinnarizine. Mov Disord 1989;4:139-146.
2. Martí-Massó JF, Carrera N, de la Puente E. Posible parkinsonismo inducido por cinaricina. Medicina Clínica (Barcelona) 1985;85: 614-616.
3. Laporte JR, Capella D. Useless drugs are not placebos: lessons from flunarizine and cinnarizine. Lancet 1986;2:853-854.
4. Giménez-Roldán S, Mateo D. Cinnarizine-induced parkinsonism. Susceptibility related to aging and essential tremor. Clin Neuropharmacol 1991;14:156-164.
5. Martí-Massó JF. Cinaricina y enfermedad de Parkinson. Estudio doble ciego frente a placebo. Neurología 1986;1:5-7.
6. García-Ruiz PJ, Mena MA, Peñafiel N, De Yébenes JG. Cinnarizine-induced parkinsonism in primates. Clin Neuropharmacol 1992;15:152-154.
7. Camps M, Reiriz J, Cutillas B, et al. Effect of cinnarizine treatment on dopamine receptors in the brain of senescent BL c57/J mice. 4th International Symposium on Calcium Antagonist: Florence, Italy; May 1989. Abstract p. 265.
8. Reiriz J. Estudio del funcionalismo dopaminérgico en el cerebro de rata tras la administración de fármacos antagonistas de los canales del calcio. Doctoral thesis. Universidad de Barcelona. 1991.
9. Ambrosio C, Stefanini E. Interaction of flunarizine with dopamine D2 and D1 receptors. Eur J Pharmacol 1991;197:221-223.
10. Ogawa N, Asanuma M, Takayama H, Sato H, Nukina Y. Effect of flunarizine hydrochloride on striatal D-2 dopamine receptors. Rinsho Shinkeigaku 1990;30:1221-1226.
11. Fernandes AC, Filipe PM, Coelho H, Manso CF. The inhibition of lipid peroxidation by cinnarizine. Possible implications to its therapeutic side effects. Biochem Pharmacol 1991;41:709-714.
12. Takada M, Kono T, Kitai ST. Flunarizine induces a transient loss of tyrosine hydroxylase immunoreactivity in nigrostriatal neurons. Brain Res 1992;590:311-315.
13. García-Ruiz PJ, García de Yébenes J, Jiménez-Jiménez FJ, Vázquez A, García-Urra D, Morales B. Parkinsonism associated with calcium channel blockers: a prospective follow-up study. Clin Neuropharmacol 1992;15:19-26.
14. Bitton V, Melamed E. Coexistence of severe parkinsonism and tardive dykinesia as side effects of neuroleptic therapy. J Clin Psychiatry 1984;45:28-30.
15. Jankovic J, Casabona J. Coexistent tardive dyskinesia and parkinsonism. Clin Neuropharmacol 1987;10:511-521.
16. Caligiuri MP, Lohr JB, Bracha HS, Jeste DV. Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry 1991;29:139-148.
17. Chouza C, Scaramelli A, Caamaño JL, De Medina O, Aljanati R, Romero S. Parkinsonism, tardive dyskinesia akathisia and depression induced by flunarizine. Lancet 1986;1:1303-1304.
18. Brandon S, McClelland HA, Protheroe C. A study of facial dyskinesia in a mental hospital population. Br J Psychiatry 1971;118: 171-184.